The trial team is the right source for information about screening, visits, study medication, and participant responsibilities
Evidently, the immediate focus of treating T2DM with glucose-lowering therapy is to reduce the associated morbidity and mortality
Market Access Strategies and Pharmaceutical Innovations in Diabetes Care and Obesity Drug Market Securing market access remains a complex challenge for pharmaceutical companies
Dawed AY, Mari A, Brown A et al (2023) Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomized controlled trials
Side effects such as hyperglycemia because of systemic suppression of -cell secretion, peripheral edema, hypotension, and headache limit its use
For many, diet and exercise arent enough